Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film, microneedle patch and biosynthesis...
Year: 2022
Extendicare Announces January 2022 Dividend of C$0.04 per Share
MARKHAM, Ontario, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as...
Christina Lake Cannabis to Present at the KCSA Cannabis Virtual Investor Conference; Announcement of Special Meeting of Class B Preferred Shareholders
CLC invites individual and institutional investors, as well as advisors and analysts, to attend our interactive presentation real-time on VirtualInvestorConferences.comVANCOUVER,...
Vigil Health Solutions to be Acquired by ASSA ABLOY
VICTORIA, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSXV: VGL) announced...
Evelo Biosciences Presents Data on EDP1815 Mechanism of Action and Supporting Ongoing Clinical Development for Inflammatory Diseases
CAMBRIDGE, Mass., Jan. 17, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines...
Immuron Receives AUD $306,154 R&D Tax Concession Refund
MELBOURNE, Australia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as...
John Dawson to retire from Oxford Biomedica
John Dawson to retire from Oxford Biomedica Oxford, UK – 17 January 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the...
OSE Immunotherapeutics Announces the Appointment of Dominique Costantini as Interim CEO Following the Departure of Alexis Peyroles
NANTES, France, Jan. 17, 2022 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the departure of...
West Island to Begin Sales in Quebec
Toronto, Ontario--(Newsfile Corp. - January 17, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"...
Alpha Blue Ocean Announces Financing Commitment of 14 Million CAD With Halo Collective
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Alpha Blue Ocean, the family office founded by Pierre Vannineuse, is delighted to announce the launch...
Self-help health market hits one million product sales for Kinetik Wellbeing as UK turns to health management at home
Interest in vital signs monitoring soars, with products relieving pressure on NHS and helping consumers to stay well at home...
XPhyto Announces Head of Sales, Europe
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 17, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera
Midatech announces extension of R&D collaboration with Janssen focused on Q-Sphera technologyABINGDON, UK / ACCESSWIRE / January 17, 2022 /...
Angle PLC Announces Concordance of Parsortix with tissue biopsy
BREAKTHROUGH STUDY DEMONSTRATES FOR THE FIRST TIME CONCORDANCE OF PARSORTIX LIQUID BIOPSY BLOOD TEST WITH INVASIVE TISSUE BIOPSY OF THE...
Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022
VANCOUVER, British Columbia, Jan. 15, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
Chronic Bronchitis Symptom/Mucus Buildup Relief – AirPhysio OPEP Device Launched
Life Wellness Healthcare has announced the addition of the lung cleaning device by AirPhysio that can provide relief for those...
iCRYO Keeps the Momentum from 2021 Moving into 2022
Houston, Texas, United States, Jan. 14, 2022 (GLOBE NEWSWIRE) -- 2021 was iCRYO’s strongest year as a company. Coming off...
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
TAIZHOU, China, Jan. 14, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty...